Lipocine Inc. (LPCN) Financial Statements (2025 and earlier)

Company Profile

Business Address 675 ARAPEEN DRIVE, SUITE 202
SALT LAKE CITY, 84108
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22,03632,53044,61819,66714,0698,078
Cash and cash equivalents4,7723,1482,95119,2179,7298,078
Short-term investments17,26429,38141,6674504,340 
Receivables528024701739
Contract with customer, asset, after allowance for credit loss  579    
Other undisclosed current assets7739451,5145,6615,54612,693
Total current assets:22,86134,13546,38025,32919,63120,809
Noncurrent Assets
Property, plant and equipment1161327 419
Long-term investments and receivables   2,022   
Long-term investments   2,022   
Contract with customer, asset, after allowance for credit loss  3,2534,050   
Other noncurrent assets242424242424
Total noncurrent assets:1403,4086,103242743
TOTAL ASSETS:23,00137,54352,48225,35319,65820,852
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,6141,6782,3063,2501,6321,158
Accounts payable1,3966001,2891,5971,182671
Accrued liabilities1,2181,0781,0161,653449487
Debt   2,3113,3333,3333,333
Estimated litigation liability   1,000   
Other undisclosed current liabilities17     
Total current liabilities:2,6321,6785,6176,5844,9654,492
Noncurrent Liabilities
Long-term debt and lease obligation    2,2573,8146,927
Long-term debt, excluding current maturities    2,2573,8146,927
Liabilities, other than long-term debt   500   
Estimated litigation liability   500   
Other undisclosed noncurrent liabilities  2307961,1704,591 
Total noncurrent liabilities:  2301,2963,4278,4066,927
Total liabilities:2,6321,9086,91210,01113,37011,418
Equity
Equity, attributable to parent20,36935,63545,57015,3426,2889,434
Common stock999742
Treasury stock, value(41)(41)(41)(41)(41)(41)
Additional paid in capital220,171219,112218,286187,408157,392147,533
Accumulated other comprehensive income (loss)7(20)(18) (0)(1)
Accumulated deficit(199,777)(183,425)(172,666)(172,032)(151,067)(138,060)
Total equity:20,36935,63545,57015,3426,2889,434
TOTAL LIABILITIES AND EQUITY:23,00137,54352,48225,35319,65820,852

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues(2,851)50016,141 165428
Gross profit:(2,851)50016,141 165428
Operating expenses(15,080)(12,619)(12,995)(17,996)(13,065)(11,754)
Operating income (loss):(17,931)(12,119)3,146(17,996)(12,900)(11,326)
Nonoperating income (expense)1,5801,361(3,780)(2,968)(343)(334)
Investment income, nonoperating1,367     
Other nonoperating income (expense)  1,361(3,780)(2,968)(343)(334)
Interest and debt expense  (27)(203)235  
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    (235)236 
Loss from continuing operations before equity method investments, income taxes:(16,351)(10,785)(837)(20,965)(13,007)(11,659)
Other undisclosed income from continuing operations before income taxes  27203   
Loss from continuing operations before income taxes:(16,351)(10,758)(634)(20,965)(13,007)(11,659)
Income tax expense(1)(1)(0)(0)(0)(1)
Loss from continuing operations:(16,352)(10,759)(634)(20,965)(13,007)(11,660)
Loss before gain (loss) on sale of properties:(634)(20,965)(13,007)(11,660)
Net loss attributable to parent:(16,352)(10,759)(634)(20,965)(13,007)(11,660)
Preferred stock dividends and other adjustments (0)     
Net loss available to common stockholders, basic:(16,352)(10,759)(634)(20,965)(13,007)(11,660)
Other undisclosed net loss available to common stockholders, diluted(213)(566)    
Net loss available to common stockholders, diluted:(16,565)(11,325)(634)(20,965)(13,007)(11,660)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(16,352)(10,759)(634)(20,965)(13,007)(11,660)
Comprehensive loss:(16,352)(10,759)(634)(20,965)(13,007)(11,660)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent28(2)(18)014
Comprehensive loss, net of tax, attributable to parent:(16,325)(10,761)(652)(20,965)(13,006)(11,656)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: